DuoBody-CD3 × CD30 (GEN3017) is a Fc-silenced IgG1 BsAb under development for the treatment of CD30-positive hematological malignancies, including cHL and anaplastic large-cell lymphoma (ALCL). This evidence concerns the gene TNFRSF8 and hematologic disorder.